← Back to Search

Blinded drug dose conditions for Healthy Subjects

Phase 1
Waitlist Available
Led By Mary M Sweeney, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 hours after capsule ingestion during experimental test session
Awards & highlights

Study Summary

This trial will study how different diets may affect a person's response to drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 hours after capsule ingestion during experimental test session
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 hours after capsule ingestion during experimental test session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Peak participant subjective ratings of drug liking
Secondary outcome measures
Participant subjective ratings of drug value

Trial Design

1Treatment groups
Experimental Treatment
Group I: Within-Subjects Dose ConditionsExperimental Treatment1 Intervention
All participants will receive the same drug conditions, but the order in which the participants receive the drug conditions will be different across participants. Thus, comparisons of the drug conditions on mood and choice will be compared within-subjects (e.g., between drug and placebo) and not between arms.

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,259 Previous Clinical Trials
14,820,651 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,631 Total Patients Enrolled
Mary M Sweeney, PhDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
109 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants still being welcomed into this experiment?

"According to the records kept on clinicaltrials.gov, this experiment is actively seeking participants, with a posting date of September 18th 2020 and its most recent edit occurring on November 8th 2022."

Answered by AI

Has the Blinded drug dose conditions protocol been validated by the FDA?

"Blinded drug dose conditions have been evaluated as a score 1 because of its Phase 1 trial status, which suggests that there is only minimal evidence to support safety and efficacy."

Answered by AI

Is this experimental research available to those in the geriatric demographic?

"According to the inclusion criteria, this clinical trial is open for individuals aged 18-45. Alternatively, 50 trials are available for minors and 372 medical studies cater to those older than 65 years of age."

Answered by AI

What is the scope of individuals receiving treatment in this experimental therapy?

"Affirmative. Per the clinicaltrials.gov record, this experiment is actively seeking participants since it's posting on September 18th 2020. A total of 36 are required and they should come from 1 specified location."

Answered by AI

To what population does this research initiative extend eligibility?

"Those hoping to be enrolled in this medical trial must have a healthy status and fall within the boundaries of 18-45 years old. In total, 36 participants are needed for proper data collection."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
What site did they apply to?
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Effects of Dietary Conditions on Drug Response
2020. "Effects of Dietary Conditions on Drug Response". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04315961.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top